Establishment and Characterization of Notch3-Overexpressing Ovarian Cancer Cell Lines
Corresponding Organization : University of Illinois at Chicago
Other organizations : Columbia University, Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, University of Virginia
Variable analysis
- Notch3 intracellular domain (codons 1664–2318) expressed using lentiviral vector pCCL
- Not explicitly mentioned
- ID8 IP2 cell line
- Cell culture conditions: DMEM with 10% FBS, 1% ITS Liquid Media Supplement (Sigma-Aldrich I3146), and 1% penicillin-streptomycin
- Human ovarian cancer cell lines: OVCAR3, OVSAHO, OVCA429, A2780, SKOV3-IP1
- Cell culture conditions for human ovarian cancer cell lines: OVCAR3, A2780, OVSAHO and SKOV3-IP1 in RPMI 1640 with 10% FBS and 1% penicillin-streptomycin; OVCA429 in MEM with 10%FBS, 1% L-glutamine, 1% NEAA, 1% Sodium pyruvate and 1% penicillin-streptomycin
- Lentiviral infection with pCCL vector (empty vector control)
- Positive control: ID8 IP2 cell line expressing Notch3 intracellular domain (codons 1664–2318) using lentiviral vector pCCL
- Negative control: ID8 IP2 cell line infected with empty pCCL vector
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!